HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Storre, J. H. Articles by Windisch, W. Search for Related Content PubMed PubMed Citation Articles by Storre, J. H. Articles by Windisch, W.

Average Volume-Assured Pressure Support in Obesity Hypoventilation^*

A Randomized Crossover Trial

Jan Hendrik Storre, MD; Benjamin Seuthe; René Fiechter, MD; Stavroula Milioglou; Michael Dreher, MD; Stephan Sorichter, MD and Wolfram Windisch, MD

Department of Pneumology, University Hospital Freiburg, Freiburg, Germany.

Correspondence to: Wolfram Windisch, MD, Department of Pneumology, University Hospital Freiburg, Killianstrasse 5, D-79106 Freiburg, Germany; e-mail: windisch{at}med1.ukl.uni-freiburg.de

Abstract

Background: Average volume-assured pressure support (AVAPS) has been introduced as a new additional mode for a bilevel pressure ventilation (BPV) device (BiPAP; Respironics; Murrysville, PA), but studies on the physiologic and clinical effects have not yet been performed. There is a particular need to better define the most efficient ventilatory treatment modality for patients with obesity hypoventilation syndrome (OHS).

Methods: In OHS patients who did not respond to therapy with continuous positive airway pressure, the effects of BPV with the spontaneous/timed (S/T) ventilation mode with and without AVAPS over 6 weeks on ventilation pattern, gas exchange, sleep quality, and health-related quality of life (HRQL) assessed by the severe respiratory insufficiency questionnaire (SRI) were prospectively investigated in a randomized crossover trial.

Results: Ten patients (mean [± SD] age, 53.5 ± 11.7 years; mean body mass index, 41.6 ± 12.1 kg/m²; mean FEV₁/FVC ratio, 79.4 ± 6.5%; mean transcutaneous PCO₂ [PtcCO₂], 58 ± 12 mm Hg) were studied. PtcCO₂ nonsignificantly decreased during nocturnal BPV-S/T by –5.6 ± 11.8 mm Hg (95% confidence interval [CI], –14.7 to 3.4 mm Hg; p = 0.188), but significantly decreased during BPV-S/T-AVAPS by –12.6 ± 12.2 mm Hg (95% CI, –22.0 to –3.2 mm Hg; p = 0.015). Pneumotachographic measurements revealed a higher individual variance of peak inspiratory pressure (p < 0.001) and a trend for lower leak volumes but also for higher tidal volumes during BPV-S/T-AVAPS. The SRI summary scale score improved from 63 ± 15 to 78 ± 14 during BPV-S/T (p = 0.004) and to 76 ± 16 during BPV-S/T-AVAPS (p = 0.014). Sleep quality and oxygen saturation also comparably improved following BPV-S/T and BPV-S/T-AVAPS.

Conclusion: BPV-S/T substantially improved oxygenation, sleep quality, and HRQL in patients with OHS. AVAPS provided additional benefits on ventilation quality, thus resulting in a more efficient decrease of PtcCO₂. However, this did not provide further clinical benefits regarding sleep quality and HRQL.

Key Words: bilevel pressure ventilation • health-related quality of life • noninvasive positive-pressure ventilation • obesity hypoventilation syndrome • sleep

This article has been cited by other articles:

				A. Ozsancak, C. D'Ambrosio, and N. S. Hill Nocturnal Noninvasive Ventilation Chest, May 1, 2008; 133(5): 1275 - 1286. [Abstract] [Full Text] [PDF]

				B. Mokhlesi and A. Tulaimat Recent Advances in Obesity Hypoventilation Syndrome Chest, October 1, 2007; 132(4): 1322 - 1336. [Abstract] [Full Text] [PDF]